Skip to main content

H5N1 Researcher Continues Legal Battle

The Dutch scientist who mutated a strain of the avian flu virus to be transmissible between mammals is headed to appeals court to protect his right to publish the work unimpeded.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Avian influenza A H5N1 viruses (gold)WIKIMEDIA, CDC/COURTESY OF CYNTHIA GOLDSMITH; JACQUELINE KATZ; SHERIF R. ZAKIThe legal battle between Ron Fouchier and the Dutch government is dragging on, with the scientist’s employer, Erasmus Medical Center in Rotterdam, appealing the September district court decision that legitimized the government’s requirement that Fouchier obtain an export license to publish his work. At issue is the potential for Fouchier’s research, which involves mutating H5N1 avain flu to become transmissible between ferrets, to be used by bioterrorists.

Fouchier published his initial report on the work in a June 2012 issue of Science, but only after obtaining an export license from the Dutch government under protest. Prior to the publication, a US biosecurity panel suggested that some of the results in Fouchier’s paper and a similar study from a group at the University of Wisconsin, Madison, should be redacted to guard against misuse of the information for nefarious purposes. This recommendation sparked a worldwide moratorium on such research, but the panel later reversed course and greenlighted the full publication of the work. In April 2012, Fouchier told Nature that he would “never apply for an export permit on a scientific manuscript for publication in a journal. We do not want to create a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo